https://thegbm.com/hutchmed-announces-nmpa-approval-for-atled-fanregratinib-for-the-treatment-of-patients-with-fgfr2-fusion-rearrangement-intrahepatic-cholangiocarcinoma/ Business news, opinion, reviews, interviews Fri, 28 Aug 2026 00:00:00 +0000 hourly 1 https://wordpress.org/?v=7.1